A promising treatment to extend the lives of glioblastoma patients is waiting on the worst form of bureaucracy ...

Then my radiation oncologist asked if I’d be interested in trying a medical device called Optune® for the treatment of glioblastoma multiforme (GBM) and walked me through the risks and benefits.

Novocure has launched Optune, its first TTFields delivery system, for the treatment of glioblastoma multiforme and potentially other solid tumor indications. For over 100 years, surgery ...

Patients living with glioblastoma, a rare cancer of the brain are calling on the province to provide coverage for Novocure’s ...

Wearable Device to Treat Brain Cancer by Using Electrical Stimulation Medically reviewed by Brigid Dwyer, MD Optune is a ...

Celgene aims to boost the effectiveness of its novel drug marizomib for aggressive brain tumour glioblastoma (GBM) by asking patients to wear a special cap. Marketed by Novocure, the Optune ...

The results are the most significant increases in both survival rates reported in a phase 3 trial for newly diagnosed GBM. Median overall survival was also improved in the Optune plus ...

Total net revenues for the year were $605.2 million, an increase of 19% year-over-year, primarily driven by continued launch success in France for Optune Gio ® for glioblastoma (GBM) and improved ...

Total net revenues for the year were $605.2 million, an increase of 19% year-over-year, primarily driven by continued launch success in France for Optune Gio ® for glioblastoma (GBM) and improved ...